share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Fubini Ross

SEC announcement ·  Jun 15 04:20
Summary by Futu AI
In a recent transaction, Fubini Ross, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), executed a stock transaction on June 13, 2024. The specific details regarding the number of shares involved, the nature of the shares, the transaction price, and the post-transaction shareholding were not disclosed in the announcement. This event may be of interest to investors following Ginkgo Bioworks' stock performance and insider activity.
In a recent transaction, Fubini Ross, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), executed a stock transaction on June 13, 2024. The specific details regarding the number of shares involved, the nature of the shares, the transaction price, and the post-transaction shareholding were not disclosed in the announcement. This event may be of interest to investors following Ginkgo Bioworks' stock performance and insider activity.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.